Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients
Description
With the changing epidemiology of COVID-19 and its impact on our daily lives, there is still an unmet need of COVID-19 therapies treating early infections to prevent progression. The current study was a randomized, parallel, double-blind, placebo
